Infant BCG vaccination study in Lithuania

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 11, 1999, Pages 956-961

  Suciliene E ^a   Rønne, Tove ^b   Plesner, A M ^b   Semenaite, B ^a   Slapkauskaite D ^a   Olesen Larsen, S ^b   Haslov K ^b  

^a Natl TB Reference Laboratory   (Lithuania)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

BCG vaccine; Tuberculin test

Indexed keywords

BCG VACCINE; TUBERCULIN;

ARTICLE; BCG VACCINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; LITHUANIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCAR; TUBERCULIN TEST; TUBERCULOSIS;

BCG VACCINE; CICATRIX; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LITHUANIA; MALE; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0344642572     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Colditz G A, Berkey C S, Mosteller F, et al. The efficacy of bacillus Calmette-Guérin vaccination of newhorns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995; 96: 29-35.
2. Al-Kassimi F A, Al-Hajjaj M S, Al-Orainey I O, Bamgboye E A. Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction? Am J Respir Crit Care Med 1995; 152: 1575-1578.
3. Curtis H M, Leek I, Bamford F N. Incidence of childhood tuberculosis after neonatal BCG vaccination. Lancet 1984; January 21: 145-148.
4. Clarke A, Rudd P. Neonatal BCG immunisation. Arch Dis Child 1992; 67: 473-474.
5. Ehrengut W, Stellmer H. Der Einfluss der BCG-Schutzimpfung auf die Kindertuberkulose in Hamburg in den Jahren 1950 bis 1971. Immunität und Infektion 1977; 5: 35-42.
6. Lanckriet C, Lévy-Bruhl D, Bingono E, Siopathis R M, Guérin N. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui. Int J Epidemiol 1995; 24: 1042-1049.
7. WHO News and Activities: WHO Statement on BCG revaccination for the prevention of tuberculosis. Bull World Health Organ 1995; 73: 805-806.
8. WHO Expert Committee on Biological Standardization. Experimental data for the selection of a reference batch of BCG. WHO/BS/802.65.
9. Fine P E M, Sterne J A C, Pönnighaus J M, Rees R J W. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 1994; 344: 1245-1249.
10. Comstock G W. Identification of an effective vaccine against tuberculosis. Am Rev Respir Dis 1988; 138: 479-480.
11. Magnus K, Edwards L B. The effect of repeated tuberculin testing on post vaccination allergy. Lancet 1955; 2: 643-644.
12. Olakowski T, Mardon K. The restorative influence of repeated tuberculin testing on tuberculin sensitivity in BCG-vaccinated schoolchildren. Bull World Health Organ 1971; 45: 649-655.
13. Aydinlioglu H, Caglayant S, Kansoy S, et al. The decline of BCG immunity after neonatal vaccination: what about revaccination at one year? Paed Perinatal Epidemiol 1993; 7: 334-338.
14. Beskow R, Bleiker M, Dahlström G, Mellbin T, Sjögren I, Stybio K. Tuberkulinkänslighet hos svenska skolbarn BCG-vaccinerade vid födelsen. Läkartidningen 1981; 78: 118-120.
15. Chhatwal J, Verma M, Thaper N, Aneja R. Waning of post vaccinal allergy after neonatal BCG vaccination. Indian Pediatr 1994; 31: 1529-1533.
16. Dawodu A H. Tuberculin conversion following BCG vaccination in preterm infants. Acta Pædiatr Scand 1985; 74: 564-567.
17. Ferreira A A, Bunn-Moreno M M, Sant' Anna C C, Carvalho Ferreira M F. BCG vaccination in low birth weight newborns: analysis of lymphocyte proliferation, 1L-2 generation and intradermal reaction to PPD. Tubercle Lung Dis 1996; 77: 476-482.
18. Kahn H, Meyerheim R, Azulay R D, Scorzclli A. BCG vaccination: a comparison of post-vaccination tuberculin sensitivity after oral and intradermal vaccination of newborn infants. Tubercle 1970; 51: 423-429.
19. Mee J, Thwaites M. BCG for neonates: a comparison of three methods. J Trop Med Hyg 1977; 80: 43-44.
20. Mussi-Pinhata M M, Goncalves A L, Foss N T. BCG vaccination of full-term infants with chronic intrauterine malnutrition: influence of immunization age on development of post-vaccination, delayed tuberculin hypersensitivity. Bull World Health Organ 1993; 71: 41-48.
21. Teulieres L, Diouf M A, Chaud P, Saint-Cyr A, Saliou P. Comparative trial of administration of half (0.05 mg) and quarter (0.025 mg) dose of intradermal Pasteur BCG on 291 infants from birth to 1 year in French Guyana. Vaccine 1991; 9: 521-524.
22. Collas R, Wright J, Jardel J P. Comparison between tuberculin allergy and the reaction to BCG vaccination. Am Rev Respir Dis 1968; 97: 1017-1031.
23. Tala-Heikkilä M, Nurmela T, Misljenovic O, Bleiker M A, Tala E. Sensitivity to PPD tuberculin and M. scrofulaceum sensitin in schoolchildren BCG vaccinated at birth. Tubercle Lung Dis 1992; 73: 87-93.
24. Stephan U, Haupt H, Scheier R, Nada A, Grimrath U, Schmitt H G. Untersuchungen zur BCG-Impfung des Neugeborenen mit dem Stamm 1331 Kopenhagen. Klin Pädiat 1986; 198: 295-298.